Finoriq research workspace
MCKESSON CORP (MCK) Institutional Holdings & 13F Ownership
McKesson Corporation provides healthcare services in the United States and internationally. Review MCK institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
- Company
- MCKESSON CORP (MCK)
- Ticker
- MCK
- Market Cap
- $100.1B
- Latest Price
- $832.61
- Industry
- Other Pharmaceuticals
MCKESSON CORP (MCK) Top Institutional Holders
Top current 13F holders indexed for MCKESSON CORP (MCK). Latest period 2026-03-31.
| Rank | Investor | Value | Portfolio | Filing |
|---|---|---|---|---|
| 1 | Stephen MandelCIK 0001061165 | $339.4M | 2.7% | Filing2026-05-15 |
| 2 | Sands CapitalCIK 0001020066 | $174.2M | 0.68% | Filing2026-05-08 |
| 3 | Brandes Investment PartnersCIK 0001015079 | $149.3M | 1.1% | Filing2026-05-15 |
| 4 | Ray DalioCIK 0001350694 | $58.3M | 0.26% | Filing2026-05-15 |
| 5 | Joel GreenblattCIK 0001510387 | $42.8M | 0.13% | Filing2026-05-15 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.